Showing results (221-230 of 342) with videos related to
Sort By:
Pageof 35
Lung Cancer (Amsterdam, Netherlands)|January 14, 2020
Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancerKatsuhiro Yoshimura, Yusuke Inoue, Kazuo Tsuchiya, et al.International Journal of Molecular Sciences|August 14, 2025
PAI-1 Inhibitor TM5441 Attenuates Emphysema and Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary DiseaseKyohei Oishi, Hideki Yasui, Yusuke Inoue, et al.BMC Cancer|August 16, 2015
Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancerYuichi Ozawa, Minako Omae, Masato Fujii, et al.BMC Cancer|January 13, 2021
Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinibYuko Oya, Tatsuya Yoshida, Kazuhiro Asada, et al.Respiratory Research|March 12, 2022
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction modelHironao Hozumi, Masato Kono, Hirotsugu Hasegawa, et al.Respiratory Research|April 5, 2022
Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional studyTakafumi Koyauchi, Yuzo Suzuki, Kazuki Sato, et al.Oncotarget|April 7, 2016
Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancerYusuke Inoue, Katsuhiro Yoshimura, Kazutaka Mori, et al.European Journal of Cancer (Oxford, England : 1990)|February 29, 2016
Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancerMasato Karayama, Naoki Inui, Tomoyuki Fujisawa, et al.Lung Cancer (Amsterdam, Netherlands)|March 24, 2020
Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancerMasato Karayama, Nobuko Yoshizawa, Masataka Sugiyama, et al.Cancer Science|June 13, 2017
Characterization of V-set and immunoglobulin domain containing 1 exerting a tumor suppressor function in gastric, lung, and esophageal cancer cellsYusuke Inoue, Shun Matsuura, Katsuhiro Yoshimura, et al.Pageof 35